Insider · CIK 0001766433

Eckelman Brendan P.

Reports to the SEC for 2 companies · LA JOLLA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001766433

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-30	Inhibrx, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−160K sh	$30.00	−$4.8M	0
2024-05-30	INBXInhibrx Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+175K sh	—	—	175,000
2024-05-30	Inhibrx, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−1.74M sh	$30.00	−$52.1M	0
2024-05-30	Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−6,667 sh	—	—	0
2024-05-30	Inhibrx, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−160K sh	$30.00	−$4.8M	0
2024-05-30	Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−26.7K sh	—	—	0
2024-05-29	INBXInhibrx Biosciences, Inc.A Award	Chief Scientific Officer	AAward	+40K sh	—	—	40,000
2024-05-29	INBXInhibrx Biosciences, Inc.A Award	Chief Scientific Officer	AAward	+40K sh	—	—	40,000
2024-05-29	INBXInhibrx Biosciences, Inc.A Award	Chief Scientific Officer	AAward	+434K sh	—	—	433,888
2024-05-28	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−300K sh	$34.30	−$10.3M	1,735,553
2024-05-22	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,510 sh	$34.12	−$85.6K	6,667
2024-05-22	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,500 sh	$34.12	−$85.3K	26,667
2024-03-13	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,898 sh	$35.33	−$67.1K	9,177
2024-03-12	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−19.9K sh	$35.25	−$701K	11,075
2024-03-12	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,152 sh	$35.25	−$146K	29,167
2024-03-11	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,877 sh	$35.30	−$243K	30,973
2024-03-11	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,681 sh	$35.33	−$236K	33,319
2024-03-08	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,150 sh	$35.75	−$76.9K	37,850
2023-03-01	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−400 sh	$24.71	−$9,883	2,035,553
2023-03-01	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−39.6K sh	$24.20	−$958K	2,035,953
2023-02-02	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−10.1K sh	$25.40	−$257K	2,076,683
2023-02-02	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−1,130 sh	$25.89	−$29.3K	2,075,553
2023-02-01	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−13.4K sh	$24.29	−$327K	2,102,104
2023-02-01	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−693 sh	$25.66	−$17.8K	2,086,803
2023-02-01	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−14.6K sh	$25.08	−$366K	2,087,496
2023-01-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−3,003 sh	$23.99	−$72K	2,115,553
2023-01-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−4,102 sh	$23.11	−$94.8K	2,118,556
2023-01-03	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−22.2K sh	$23.41	−$520K	2,133,340
2023-01-03	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−8,598 sh	$24.36	−$209K	2,124,742
2023-01-03	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−2,084 sh	$25.09	−$52.3K	2,122,658
2023-01-03	Inhibrx, Inc.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+40K sh	—	—	40,000
2022-12-06	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−20.9K sh	$26.83	−$562K	2,174,626
2022-12-06	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−1,392 sh	$28.46	−$39.6K	2,155,553
2022-12-06	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−17.7K sh	$27.57	−$487K	2,156,945
2022-11-01	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−12.3K sh	$33.90	−$419K	2,195,553
2022-11-01	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−27.7K sh	$33.34	−$922K	2,207,902
2022-10-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−6,207 sh	$26.06	−$162K	2,267,898
2022-10-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−100 sh	$30.52	−$3,052	2,235,553
2022-10-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−10.9K sh	$29.68	−$323K	2,235,653
2022-10-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−5,954 sh	$28.97	−$172K	2,246,546
2022-10-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−4,262 sh	$27.76	−$118K	2,252,500
2022-10-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−1,448 sh	$24.67	−$35.7K	2,274,105
2022-10-04	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−11.1K sh	$26.78	−$298K	2,256,762
2022-09-13	Inhibrx, Inc.G Gift	Chief Scientific Officer	GGift	+80K sh	—	—	160,000
2022-09-13	Inhibrx, Inc.G Gift	Chief Scientific Officer	GGift	−160K sh	—	—	2,275,553
2022-09-13	Inhibrx, Inc.G Gift	Chief Scientific Officer	GGift	+80K sh	—	—	160,000
2022-09-06	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−37.5K sh	$14.86	−$557K	2,438,046
2022-09-06	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−2,493 sh	$15.66	−$39K	2,435,553
2022-08-03	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−15.5K sh	$18.47	−$286K	2,475,553
2022-08-02	Inhibrx, Inc.S Sale	Chief Scientific Officer	SSale	−24.5K sh	$17.70	−$434K	2,491,053

Recent filings

Accepted (ET)
May 304
Eckelman Brendan P.0000950142-24-001490
SEC(opens sec.gov)
May 304
Eckelman Brendan P.0000950142-24-001497
SEC(opens sec.gov)
May 244
Eckelman Brendan P.0001739614-24-000033
SEC(opens sec.gov)
Mar 154
Eckelman Brendan P.0001739614-24-000017
SEC(opens sec.gov)
Mar 124
Eckelman Brendan P.0001739614-24-000013
SEC(opens sec.gov)
Mar 24
Eckelman Brendan P.0001739614-23-000016
SEC(opens sec.gov)

Companies

Address

C/O INHIBRX, INC. 11025 NORTH TORREY PINES ROAD, SUITE 200

LA JOLLA, CA, 92037